These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23423190)

  • 1. Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis.
    Serres S; Bristow C; de Pablos RM; Merkler D; Soto MS; Sibson NR; Anthony DC
    J Cereb Blood Flow Metab; 2013 May; 33(5):744-53. PubMed ID: 23423190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nobiletin attenuates inflammation via modulating proinflammatory and antiinflammatory cytokine expressions in an autoimmune encephalomyelitis mouse model.
    Yarim GF; Yarim M; Sozmen M; Gokceoglu A; Ertekin A; Kabak YB; Karaca E
    Fitoterapia; 2022 Jan; 156():105099. PubMed ID: 34896483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis.
    Khorooshi R; Mørch MT; Holm TH; Berg CT; Dieu RT; Dræby D; Issazadeh-Navikas S; Weiss S; Lienenklaus S; Owens T
    Acta Neuropathol; 2015 Jul; 130(1):107-18. PubMed ID: 25869642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adapted focal experimental autoimmune encephalomyelitis to allow MRI exploration of multiple sclerosis features.
    Tourdias T; Hiba B; Raffard G; Biran M; Nishiguchi T; Aussudre J; Franconi JM; Brochet B; Petry KG; Dousset V
    Exp Neurol; 2011 Aug; 230(2):248-57. PubMed ID: 21575634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic inflammatory response reactivates immune-mediated lesions in rat brain.
    Serres S; Anthony DC; Jiang Y; Broom KA; Campbell SJ; Tyler DJ; van Kasteren SI; Davis BG; Sibson NR
    J Neurosci; 2009 Apr; 29(15):4820-8. PubMed ID: 19369550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-β in multiple sclerosis.
    Lee LF; Axtell R; Tu GH; Logronio K; Dilley J; Yu J; Rickert M; Han B; Evering W; Walker MG; Shi J; de Jong BA; Killestein J; Polman CH; Steinman L; Lin JC
    Sci Transl Med; 2011 Jul; 3(93):93ra68. PubMed ID: 21795588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of brain antigens recognized by autoantibodies in experimental autoimmune encephalomyelitis-induced animals treated with etomoxir or interferon-β.
    Mørkholt AS; Kastaniegaard K; Trabjerg MS; Gopalasingam G; Niganze W; Larsen A; Stensballe A; Nielsen S; Nieland JD
    Sci Rep; 2018 May; 8(1):7092. PubMed ID: 29728570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of MRI signatures in pattern I and II multiple sclerosis models.
    Serres S; Anthony DC; Jiang Y; Campbell SJ; Broom KA; Khrapitchev A; Sibson NR
    NMR Biomed; 2009 Dec; 22(10):1014-24. PubMed ID: 19489017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickness behaviour is induced by a peripheral CXC-chemokine also expressed in multiple sclerosis and EAE.
    Campbell SJ; Meier U; Mardiguian S; Jiang Y; Littleton ET; Bristow A; Relton J; Connor TJ; Anthony DC
    Brain Behav Immun; 2010 Jul; 24(5):738-46. PubMed ID: 20138139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of IFN-β1a and IFN-β1b treatment on the expression of cytokines, inducible NOS (NOS type II), and myelin proteins in animal model of multiple sclerosis.
    Lubina-Dąbrowska N; Stepień A; Sulkowski G; Dąbrowska-Bouta B; Langfort J; Chalimoniuk M
    Arch Immunol Ther Exp (Warsz); 2017 Aug; 65(4):325-338. PubMed ID: 28299403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of interferon-β in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes.
    Inoue M; Shinohara ML
    Immunology; 2013 May; 139(1):11-8. PubMed ID: 23360426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization of acute focal lesions in rats with experimental autoimmune encephalomyelitis by magnetic nanoparticles, comparing different MRI sequences including phase imaging.
    Hunger M; Budinger E; Zhong K; Angenstein F
    J Magn Reson Imaging; 2014 May; 39(5):1126-35. PubMed ID: 24115505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself.
    Burm SM; Peferoen LA; Zuiderwijk-Sick EA; Haanstra KG; 't Hart BA; van der Valk P; Amor S; Bauer J; Bajramovic JJ
    J Neuroinflammation; 2016 Jun; 13(1):138. PubMed ID: 27266875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis.
    Elo P; Tadayon S; Liljenbäck H; Teuho J; Käkelä M; Koskensalo K; Saunavaara V; Virta J; Veres TZ; Kiviniemi A; Saraste A; Marjamäki P; Airas L; Jalkanen S; Roivainen A
    J Neuroinflammation; 2018 May; 15(1):128. PubMed ID: 29716612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-beta directly influences monocyte infiltration into the central nervous system.
    Floris S; Ruuls SR; Wierinckx A; van der Pol SM; Döpp E; van der Meide PH; Dijkstra CD; De Vries HE
    J Neuroimmunol; 2002 Jun; 127(1-2):69-79. PubMed ID: 12044977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription cofactor GRIP1 differentially affects myeloid cell-driven neuroinflammation and response to IFN-β therapy.
    Mimouna S; Rollins DA; Shibu G; Tharmalingam B; Deochand DK; Chen X; Oliver D; Chinenov Y; Rogatsky I
    J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33045064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis.
    Paintlia AS; Paintlia MK; Singh I; Singh AK
    Am J Pathol; 2006 Sep; 169(3):1012-25. PubMed ID: 16936274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Lin CC; Edelson BT
    J Immunol; 2017 Jun; 198(12):4553-4560. PubMed ID: 28583987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome.
    Inoue M; Williams KL; Oliver T; Vandenabeele P; Rajan JV; Miao EA; Shinohara ML
    Sci Signal; 2012 May; 5(225):ra38. PubMed ID: 22623753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.